BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 11204125)

  • 41. Fluconazole susceptibility of Italian Candida dubliniensis clinical isolates determined by reference and simplified tests.
    Giammanco GM; Pecorella S; Distefano S; Pecoraro V; Milici ME; Pizzo G
    New Microbiol; 2001 Oct; 24(4):397-404. PubMed ID: 11718378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Iranian HIV/AIDS patients with oropharyngeal candidiasis: identification, prevalence and antifungal susceptibility of Candida species.
    Khedri S; Santos ALS; Roudbary M; Hadighi R; Falahati M; Farahyar S; Khoshmirsafa M; Kalantari S
    Lett Appl Microbiol; 2018 Oct; 67(4):392-399. PubMed ID: 30019443
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predisposing factors for oropharyngeal colonization of yeasts in human immunodeficiency virus-infected patients: a prospective cross-sectional study.
    Lin JN; Lin CC; Lai CH; Yang YL; Chen HT; Weng HC; Hsieh LY; Kuo YC; Lauderdale TL; Tseng FC; Lin HH; Lo HJ
    J Microbiol Immunol Infect; 2013 Apr; 46(2):129-35. PubMed ID: 22921200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro and in vivo activity of tea tree oil against azole-susceptible and -resistant human pathogenic yeasts.
    Mondello F; De Bernardis F; Girolamo A; Salvatore G; Cassone A
    J Antimicrob Chemother; 2003 May; 51(5):1223-9. PubMed ID: 12668571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Candidemia in a tertiary care cancer center: in vitro susceptibility and its association with outcome of initial antifungal therapy.
    Antoniadou A; Torres HA; Lewis RE; Thornby J; Bodey GP; Tarrand JP; Han XY; Rolston KV; Safdar A; Raad II; Kontoyiannis DP
    Medicine (Baltimore); 2003 Sep; 82(5):309-21. PubMed ID: 14530780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [In vitro susceptibility of Candida strains to fluconazole and amphotericin B].
    Fernández Andreu CM; Martínez Machin G; Illnait Zaragozi MT; Perurena Lancha MR; Aguila Sánchez A; Galloso Brito M
    Rev Cubana Med Trop; 2007; 59(2):113-8. PubMed ID: 23427444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
    Cernicka J; Subik J
    Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Correlation between resistance testing and typing of Candida albicans--isolates from AIDS patients and chronic recurrent oral candidiasis].
    Ruhnke M; Tennagen I; Engelmann E
    Mycoses; 1994; 37 Suppl 1():60-3. PubMed ID: 7854368
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Candida fermentati from HIV patients in Chennai, South India.
    Umamaheswari K; Menon T
    Int J Infect Dis; 2008 Nov; 12(6):e153-4. PubMed ID: 18650108
    [No Abstract]   [Full Text] [Related]  

  • 50. [Fluconazole-resistant Candida species from HIV infected patients with recurrent Candida stomatitis: cross resistance to itraconazole and ketoconazole].
    Metzger S; Hofmann H
    Mycoses; 1997; 40 Suppl 1():56-63. PubMed ID: 9417515
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dynamic analysis of oral Candida carriage, distribution, and antifungal susceptibility in HIV-infected patients during the first year of highly active antiretroviral therapy in Guangxi, China.
    Jiang L; Yong X; Li R; Peng Y; Liu W; Qin Q; Zhang L; Liu Z; Liang H; Tao R
    J Oral Pathol Med; 2014 Oct; 43(9):696-703. PubMed ID: 24931443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple oral Candida infections in patients with Sjogren's syndrome -- prevalence and clinical and drug susceptibility profiles.
    Yan Z; Young AL; Hua H; Xu Y
    J Rheumatol; 2011 Nov; 38(11):2428-31. PubMed ID: 21844143
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prevalence and antifungal susceptibility of Candida albicans and its related species Candida dubliniensis and Candida africana isolated from vulvovaginal samples in a hospital of Argentina.
    Theill L; Dudiuk C; Morano S; Gamarra S; Nardin ME; Méndez E; Garcia-Effron G
    Rev Argent Microbiol; 2016; 48(1):43-9. PubMed ID: 26922471
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Susceptibility to fluconazole and itraconazole in isolates of Candida spp. from HIV-positive and HIV-negative patients].
    Bernal S; Gutiérrez MJ; Serrano MC; Chávez M; Valverde A; Quindós G; Mazuelos EM
    Rev Esp Quimioter; 2000 Mar; 13(1):60-3. PubMed ID: 10855026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
    Samaranayake YH; Samaranayake LP; Tsang PC; Wong KH; Yeung KW
    J Oral Pathol Med; 2001 Jul; 30(6):336-46. PubMed ID: 11459319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study.
    Lee MK; Kim HR; Kang JO; Kim MN; Kim EC; Kim JS; Kim JJ; Park YJ; Song W; Shin JH; Lee KM; Lee NY; Lee M; Lee WG; Lee CK; Lee HJ; Chang CL; Choi TY
    Mycoses; 2007 Mar; 50(2):148-9. PubMed ID: 17305780
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter.
    Wu CJ; Lee HC; Yang YL; Chang CM; Chen HT; Lin CC; Lee NY; Chu WL; Hsieh LY; Wang YL; Lauderale TL; Tseng FC; Ko NY; Ko WC; Lo HJ
    Clin Microbiol Infect; 2012 May; 18(5):485-90. PubMed ID: 21939471
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of Candida dubliniensis in oropharyngeal samples of Turkish HIV-positive patients.
    Tekeli A; Koyuncu E; Dolapci I; Guven GS; Sahin GO; Uzun O
    Mycoses; 2005 May; 48(3):197-201. PubMed ID: 15842337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Point prevalence, microbiology and antifungal susceptibility patterns of oral Candida isolates colonizing or infecting Mexican HIV/AIDS patients and healthy persons.
    Sánchez-Vargas LO; Ortiz-López NG; Villar M; Moragues MD; Aguirre JM; Cashat-Cruz M; Lopez-Ribot JL; Gaitán-Cepeda LA; Quindós G
    Rev Iberoam Micol; 2005 Jun; 22(2):83-92. PubMed ID: 16107165
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [INVESTIGATION ON ANTIFUNGAL SUSCEPTIBILITY OF CANDIDA YEASTS IN PREGNANT PATIENTS WITH CONFIRMED VULVOVAGINAL CANDIDIASIS AND THEIR NEWBORNS.].
    Chokoeva A; Kouzmanov A; Ivanova Z; Zisova L; Amalie G; Petleshkova P; Miteva-Katrandzhieva T; Krasteva M; Uchikova E
    Akush Ginekol (Sofiia); 2016; 55(4):20-29. PubMed ID: 29370489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 57.